These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36680289)

  • 1. Humoral Immune Response Profile of COVID-19 Reveals Severity and Variant-Specific Epitopes: Lessons from SARS-CoV-2 Peptide Microarray.
    Acharjee A; Ray A; Salkar A; Bihani S; Tuckley C; Shastri J; Agrawal S; Duttagupta S; Srivastava S
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope-specific antibody responses differentiate COVID-19 outcomes and variants of concern.
    Voss C; Esmail S; Liu X; Knauer MJ; Ackloo S; Kaneko T; Lowes L; Stogios P; Seitova A; Hutchinson A; Yusifov F; Skarina T; Evdokimova E; Loppnau P; Ghiabi P; Haijan T; Zhong S; Abdoh H; Hedley BD; Bhayana V; Martin CM; Slessarev M; Chin-Yee B; Fraser DD; Chin-Yee I; Li SS
    JCI Insight; 2021 Jul; 6(13):. PubMed ID: 34081630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Spike Protein Epitopes by Assessing the Dynamics of Humoral Immune Responses in Moderate COVID-19.
    Chen L; Pang P; Qi H; Yan K; Ren Y; Ma M; Cao R; Li H; Hu C; Li Y; Xia J; Lai D; Dong Y; Jiang H; Zhang H; Shan H; Tao S; Liu S
    Front Immunol; 2022; 13():770982. PubMed ID: 35371042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal and proteome-wide analyses of antibodies in COVID-19 patients reveal features of the humoral immune response to SARS-CoV-2.
    Wang J; Yang Y; Liang T; Yang N; Li T; Zheng C; Ning N; Luo D; Yang X; He Z; Yang G; Li B; Gao J; Yu W; Gong S; Huang Y; Li J; Wang H; Zhang H; Zhang T; Li P; Li Y; Dai J; Zhang X; Li B; Yu X; Wang H
    J Adv Res; 2022 Mar; 37():209-219. PubMed ID: 35475278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal immune profiling reveals dominant epitopes mediating long-term humoral immunity in COVID-19-convalescent individuals.
    Li M; Liu J; Lu R; Zhang Y; Du M; Xing M; Wu Z; Kong X; Zhu Y; Zhou X; Hu L; Zhang C; Zhou D; Jin X
    J Allergy Clin Immunol; 2022 Apr; 149(4):1225-1241. PubMed ID: 35074422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune profiling of SARS-CoV-2 epitopes in asymptomatic and symptomatic pediatric and adult patients.
    Tornesello AL; Botti C; Micillo A; Labonia F; Arpino S; Isgrò MA; Meola S; Russo L; Cavalcanti E; Sale S; Nicastro C; Atripaldi L; Starita N; Cerasuolo A; Reimer U; Holenya P; Buonaguro L; Buonaguro FM; Tornesello ML
    J Transl Med; 2023 Feb; 21(1):123. PubMed ID: 36788606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19.
    Ravichandran S; Tang J; Grubbs G; Lee Y; Pourhashemi S; Hussaini L; Lapp SA; Jerris RC; Singh V; Chahroudi A; Anderson EJ; Rostad CA; Khurana S
    Nat Immunol; 2021 Nov; 22(11):1452-1464. PubMed ID: 34611361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope Mapping on Microarrays Highlights a Sequence on the N Protein with Strong Immune Response in SARS-CoV-2 Patients.
    Frigerio R; Musicò A; Strada A; Mussida A; Gagni P; Bergamaschi G; Chiari M; Barzon L; Gori A; Cretich M
    Methods Mol Biol; 2023; 2578():209-217. PubMed ID: 36152290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide microarray analysis of in-silico predicted B-cell epitopes in SARS-CoV-2 sero-positive healthcare workers in Bulawayo, Zimbabwe.
    Vengesai A; Naicker T; Midzi H; Kasambala M; Muleya V; Chipako I; Choto E; Moyo P; Mduluza T
    Acta Trop; 2023 Feb; 238():106781. PubMed ID: 36460093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.
    Sasson JM; Campo JJ; Carpenter RM; Young MK; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Teng AA; Pablo JV; Liang X; Yee A; Petri WA; Camerini D
    mBio; 2021 Jun; 12(3):e0122921. PubMed ID: 34182775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic landscape mapping of humoral immunity to SARS-CoV-2 identifies non-structural protein antibodies associated with the survival of critical COVID-19 patients.
    Cheng L; Zhang X; Chen Y; Wang D; Zhang D; Yan S; Wang H; Xiao M; Liang T; Li H; Xu M; Hou X; Dai J; Wu X; Li M; Lu M; Wu D; Tian R; Zhao J; Zhang Y; Cao W; Wang J; Yan X; Zhou X; Liu Z; Xu Y; He F; Li Y; Yu X; Zhang S
    Signal Transduct Target Ther; 2021 Aug; 6(1):304. PubMed ID: 34404759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1.
    Pagano S; Yerly S; Meyer B; Juillard C; Suh N; Le Terrier C; Daguer JP; Farrera-Soler L; Barluenga S; Piumatti G; Hartley O; Lemaitre B; Eberhardt CS; Siegrist CA; Eckerle I; Stringhini S; Guessous I; Kaiser L; Pugin J; Winssinger N; Vuilleumier N
    Eur J Clin Invest; 2021 Nov; 51(11):e13661. PubMed ID: 34324704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients.
    Schwarz T; Heiss K; Mahendran Y; Casilag F; Kurth F; Sander LE; Wendtner CM; Hoechstetter MA; Müller MA; Sekul R; Drosten C; Stadler V; Corman VM
    Front Immunol; 2021; 12():629185. PubMed ID: 33833755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients.
    Li Y; Ma ML; Lei Q; Wang F; Hong W; Lai DY; Hou H; Xu ZW; Zhang B; Chen H; Yu C; Xue JB; Zheng YX; Wang XN; Jiang HW; Zhang HN; Qi H; Guo SJ; Zhang Y; Lin X; Yao Z; Wu J; Sheng H; Zhang Y; Wei H; Sun Z; Fan X; Tao SC
    Cell Rep; 2021 Mar; 34(13):108915. PubMed ID: 33761319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide microarray-based analysis of antibody responses to SARS-CoV-2 identifies unique epitopes with potential for diagnostic test development.
    Holenya P; Lange PJ; Reimer U; Woltersdorf W; Panterodt T; Glas M; Wasner M; Eckey M; Drosch M; Hollidt JM; Naumann M; Kern F; Wenschuh H; Lange R; Schnatbaum K; Bier FF
    Eur J Immunol; 2021 Jul; 51(7):1839-1849. PubMed ID: 33772767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Barcoded Flow Cytometric Assay to Explore the Antibody Responses Against SARS-CoV-2 Spike and Its Variants.
    Vesper N; Ortiz Y; Bartels-Burgahn F; Yang J; de la Rosa K; Tenbusch M; Schulz S; Finzel S; Jäck HM; Eibel H; Voll RE; Reth M
    Front Immunol; 2021; 12():730766. PubMed ID: 34630410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel precision-serology assay for SARS-CoV-2 infection based on linear B-cell epitopes of Spike protein.
    Lundin SB; Kann H; Fulurija A; Andersson B; Nakka SS; Andersson LM; Gisslén M; Harandi AM
    Front Immunol; 2023; 14():1166924. PubMed ID: 37251407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.
    Zhan W; Tian X; Zhang X; Xing S; Song W; Liu Q; Hao A; Hu Y; Zhang M; Ying T; Chen Z; Lan F; Sun L
    J Virol; 2022 Aug; 96(16):e0048022. PubMed ID: 35924918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Infection-and mRNA Vaccine-induced Humoral Immunity among Schoolchildren in Hawassa, Ethiopia.
    Merid Y; Tekleselasie W; Tesfaye E; Gadisa A; Fentahun D; Abate A; Alemu A; Mihret A; Mulu A; Gelanew T
    Front Immunol; 2023; 14():1163688. PubMed ID: 37398668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.